Ignite Creation Date:
2025-12-24 @ 11:37 PM
Ignite Modification Date:
2026-02-10 @ 12:29 PM
Study NCT ID:
NCT03944356
Status:
COMPLETED
Last Update Posted:
2025-03-12
First Post:
2019-04-26
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
BRAF-/MEK-Inhibition With Dabrafenib and Trametinib in Melanoma Patients
Sponsor:
EuMelaReg gGmbH
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Melanoma | View |
Keywords: